1. Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436–1444.
2. Huang H, et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. Journal of Clinical Microbiology 2006; 44: 2423–2427.
3. Davis SL, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. Journal of Clinical Microbiology 2007; 45: 1705–1711.
4. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Laboratory Investigation 2007; 87: 3–9.
5. Gosbell IB. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Internal Medicine Journal 2005; 35: S120–S135.
6. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. New England Journal of Medicine 2007; 357: 380–390.
7. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison – Mississippi, 2000. Morbidity and Mortality Weekly Report 2001; 50: 919–922.
8. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities – Georgia, California, and Texas, 2001–2003. Morbidity and Mortality Weekly Report 2003; 52: 992–996.
9. Turabelidze G, et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerging Infectious Diseases 2006; 12: 422–427.
10. Como-Sabette K, et al. Methicillin-resistant Staphylococcus aureus at canoe camp. Emerging Infectious Diseases 2006; 12: 1759–1761.
11. Borer A, et al. Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerging Infectious Diseases 2002; 8: 966–970.
12. LaMar JE, et al. Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Military Medicine 2003; 168: 135–138.
13. Zinderman CE, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerging Infectious Diseases 2004; 10: 941–944.
14. Campbell KM, et al. Risk Factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. Journal of Clinical Microbiology 2004; 42: 4050–4053.
15. Baggett HC, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in Southwestern Alaska. Infection Control Hospital Epidemiology 2003; 24: 397–402.
16. Baggett HC, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. Journal of Infectious Diseases 2004; 189: 1565–1573.
17. Gilbert M, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal 2006; 175: 149–154.
18. Coronado F, et al. Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community. Epidemiology and Infection 2007; 135: 492–501.
19. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerging Infectious Diseases 2005; 11: 526–532.
20. Müller-Premru M, et al. New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team. European Journal of Clinical Microbiology and Infectious Diseases 2005; 24: 848–850.
21. Lindenmayer JM, et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Archives of Internal Medicine 1998; 158: 895–899.
22. Stacey AR, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a rugby football team. British Journal of Sports Medicine 1998; 32: 153–154.
23. Begier EM, et al. A high-morbidity outbreak of methicillin resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clinical Infectious Diseases 2004; 39: 1446–1453.
24. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants – Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. Morbidity and Mortality Weekly Report 2003; 52: 793–795.
25. Rihn JA, et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. The Pediatric Infectious Disease Journal 2005; 24: 841–843.
26. Kazakova SV, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 2005; 352: 468–475.
27. Romano R, Lu D, Holtom P. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. Journal of Athletic Training 2006; 41: 141–145.
28. Sosin DM, et al. An outbreak of furunculosis among high school athletes. American Journal of Sports Medicine 1989; 17: 828–832.
29. Bartlett PC, Martin RJ, Cahill BR. Furunculosis in a high school football team. American Journal of Sports Medicine 1982; 10: 371–374.
30. Gorwitz RJ, et al. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. Atlanta, GA, USA: US Department of Health and Human Services, 2006 (http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html). Accessed 3 August 2007.
31. McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113–5120.
32. Walker N, Gupta R, Cheesbrough J. Blood pressure cuffs: friend or foe? Journal of Hospital Infection 2006; 63: 167–169.
33. Ormerod JOM, et al. Risk of MRSA transmission from tourniquets. Journal of Hospital Infection 2006; 64: 300–301.
34. French G, et al. Contamination of doctors' and nurses' pens with nosocomial pathogens. Lancet 1998; 351: 213.
35. Ndawula EM, Brown L. Mattresses as reservoirs of epidemic methicillin-resistant Staphylococcus aureus. Lancet 1991; 337: 488.
36. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clinical Infectious Diseases 2004; 39: 1182–1189.
37. Beard-Peglar MA, Stubbs E, Vickery AM. Observations on the resistance to drying of staphylococcal strains. Journal of Medical Microbiology 1988; 26: 251–255.
38. Duckworth GJ, Jordens JZ. Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. Journal of Medical Microbiology 1990; 32: 195–200.
39. Sehulster L, et al. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Report Recommendations and Reports 2003; 52: 1–42.
40. United States Environmental Protection Agency. List H. EPA's registered products effective against methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant Enterococcus faecalis or faecium (VRE) (http://www.epa.gov/oppad001/list_h_mrsa_vre.pdf). Accessed 11 January 2008.